User:Mr. Ibrahem/Tezepelumab

Tezepelumab, sold under the brand name Tezspire, is a medication used for the treatment of asthma. Specifically it is used for severe asthma, which is not controlled by other medication, in those at least 12 years old. It is given by injection under the skin every 4 weeks.

The most common side effects include joint pain and sore throat. Other side effects may include allergic reactions. While there is no evidence of harm in pregnancy, such use has not been well studied. It is a monoclonal antibody that blocks thymic stromal lymphopoietin (TSLP), resulting in less airway inflammation.

Tezepelumab was approved for medical use in the United States in 2021 and Europe in 2022. In the United States it costs about 48,000 USD per year as of 2022. While approved in the UK it was not yet marketed as of 2022.